A Study to Assess the Hypersensitivity to TAK-880 Compared to Gammagard S/D in Blood of Children, Teenagers and Adults

Clinical trial NCT05269082 · COMPLETED

Trial details

NCT number: NCT05269082
Sponsor: Takeda
Status: COMPLETED
Study type: OBSERVATIONAL

Drug Hypersensitivity

Start date: 2022-04-05
Primary completion: 2022-09-19
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.